ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Overdiagnosis Since Advent Of Prostate Cancer Screening

September 25, 2009

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

January 5, 1979